CN102172409A - 一种用于乌头类中药毒性效价检测的生物检定方法及装置 - Google Patents
一种用于乌头类中药毒性效价检测的生物检定方法及装置 Download PDFInfo
- Publication number
- CN102172409A CN102172409A CN 201110008195 CN201110008195A CN102172409A CN 102172409 A CN102172409 A CN 102172409A CN 201110008195 CN201110008195 CN 201110008195 CN 201110008195 A CN201110008195 A CN 201110008195A CN 102172409 A CN102172409 A CN 102172409A
- Authority
- CN
- China
- Prior art keywords
- animal
- diluent
- test sample
- standard substance
- toxicity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 231100000419 toxicity Toxicity 0.000 title claims abstract description 32
- 230000001988 toxicity Effects 0.000 title claims abstract description 32
- 238000004166 bioassay Methods 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 11
- 241000173529 Aconitum napellus Species 0.000 title abstract 4
- 229940023019 aconite Drugs 0.000 title abstract 4
- 229940126680 traditional chinese medicines Drugs 0.000 title abstract 4
- 238000012360 testing method Methods 0.000 claims description 33
- 239000003085 diluting agent Substances 0.000 claims description 29
- 241001465754 Metazoa Species 0.000 claims description 27
- 241000227129 Aconitum Species 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 19
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 claims description 17
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 claims description 17
- 229940039750 aconitine Drugs 0.000 claims description 17
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 239000002398 materia medica Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 7
- 239000007924 injection Substances 0.000 claims description 7
- XUHJBXVYNBQQBD-UHFFFAOYSA-N mesaconitine Natural products COC1CC(O)C2(COC)CN(C)C3C(C(C45)(OC(C)=O)C(O)C6OC)C(OC)C2C31C4CC6(O)C5OC(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-UHFFFAOYSA-N 0.000 claims description 6
- XUHJBXVYNBQQBD-GQPWXMLZSA-N molport-002-525-145 Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H]6[C@@H](OC)[C@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H]4N(C)C[C@@]6([C@@H](C[C@@H]5OC)O)COC)C(=O)C1=CC=CC=C1 XUHJBXVYNBQQBD-GQPWXMLZSA-N 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 210000003462 vein Anatomy 0.000 claims description 5
- DPMGVDIWDTYPMP-UHFFFAOYSA-N Hypaconitine Natural products COCC12CCC(OC)C3(CN(C)C1)C4CC5(O)C(OC)C(O)C(CC(OC)C23)(OC(=O)C)C4C5OC(=O)c6ccccc6 DPMGVDIWDTYPMP-UHFFFAOYSA-N 0.000 claims description 4
- 241000700159 Rattus Species 0.000 claims description 4
- 230000037396 body weight Effects 0.000 claims description 4
- FIDOCHXHMJHKRW-GKVQVCCJSA-N hypaconitine Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@]45[C@@H](OC)CC[C@@]6([C@H]4[C@@H](OC)[C@H]([C@@](OC(C)=O)([C@H]31)[C@@H](O)[C@H]2OC)[C@H]5N(C)C6)COC)C(=O)C1=CC=CC=C1 FIDOCHXHMJHKRW-GKVQVCCJSA-N 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000012086 standard solution Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 206010038669 Respiratory arrest Diseases 0.000 claims description 3
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 3
- 229960004756 ethanol Drugs 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 210000001747 pupil Anatomy 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 241000700199 Cavia porcellus Species 0.000 claims description 2
- 241000272201 Columbiformes Species 0.000 claims description 2
- 241000699670 Mus sp. Species 0.000 claims description 2
- 241000270959 Pelophylax nigromaculatus Species 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 3
- 239000012567 medical material Substances 0.000 description 17
- 239000003814 drug Substances 0.000 description 14
- 229930013930 alkaloid Natural products 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 5
- 231100000668 minimum lethal dose Toxicity 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 231100000636 lethal dose Toxicity 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001141 propulsive effect Effects 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110008195 CN102172409B (zh) | 2011-01-14 | 2011-01-14 | 一种用于乌头类中药毒性效价检测的生物检定方法及装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110008195 CN102172409B (zh) | 2011-01-14 | 2011-01-14 | 一种用于乌头类中药毒性效价检测的生物检定方法及装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102172409A true CN102172409A (zh) | 2011-09-07 |
CN102172409B CN102172409B (zh) | 2012-07-18 |
Family
ID=44515773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110008195 Expired - Fee Related CN102172409B (zh) | 2011-01-14 | 2011-01-14 | 一种用于乌头类中药毒性效价检测的生物检定方法及装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102172409B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113406072A (zh) * | 2021-05-21 | 2021-09-17 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种活心丸急性毒性的检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1369278A (zh) * | 2001-02-16 | 2002-09-18 | 中国科学院长春应用化学研究所 | 附子、乌头类剧毒中药的炮制方法 |
CN1872253A (zh) * | 2006-04-26 | 2006-12-06 | 云南植物药业有限公司 | 云南红药片的质量控制方法 |
-
2011
- 2011-01-14 CN CN 201110008195 patent/CN102172409B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1369278A (zh) * | 2001-02-16 | 2002-09-18 | 中国科学院长春应用化学研究所 | 附子、乌头类剧毒中药的炮制方法 |
CN1872253A (zh) * | 2006-04-26 | 2006-12-06 | 云南植物药业有限公司 | 云南红药片的质量控制方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113406072A (zh) * | 2021-05-21 | 2021-09-17 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种活心丸急性毒性的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102172409B (zh) | 2012-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109085262A (zh) | 血清血浆药物萃取组合物及其用途 | |
CN106198782A (zh) | 一种可同时实现苦丁茶中18个组份的含量分析和相似度评价的质量控制方法 | |
CN108226321A (zh) | 荜铃胃痛颗粒的指纹图谱检测方法及其指纹图谱 | |
CN102119961A (zh) | 一种复方丹参滴丸的检测方法 | |
CN102692470A (zh) | 测定含雄黄的药物中可溶性砷和价态砷的含量的方法 | |
CN105301136B (zh) | 一种九味熄风颗粒成分定量检测方法及其指纹图谱构建方法 | |
CN106802327B (zh) | 一种建立儿泻停药物制剂的指纹图谱的方法 | |
CN103926332A (zh) | 一种同时测定半夏提取物中尿苷、鸟苷和腺苷含量的超高效液相色谱方法 | |
CN104730158A (zh) | 一种加味藿香正气软胶囊的含量测定方法 | |
CN109633043A (zh) | 一种红景天注射液hplc指纹图谱的建立方法及其标准图谱 | |
CN102172409B (zh) | 一种用于乌头类中药毒性效价检测的生物检定方法及装置 | |
CN105424833A (zh) | 一种fkⅳ号颗粒成分检测方法 | |
CN104730167B (zh) | 一种盐酸氯卡色林对映异构体检测方法及其质量控制标准 | |
CN106525994A (zh) | 一种氨酚曲马多胶囊有关物质的测定方法 | |
CN102706984A (zh) | 采用高效液相测定清肺消炎丸中盐酸麻黄碱含量的方法 | |
CN103230453A (zh) | 一种茵陈蒿汤配方颗粒及其制备方法和检测方法 | |
CN106124682A (zh) | 一种刺五加注射液的成分检验方法 | |
CN104914194A (zh) | 一种用气相色谱仪检测薄荷素油滴丸中薄荷脑含量的方法 | |
CN108593797A (zh) | 儿科七厘散中可溶性砷及形态砷的测定方法 | |
CN108120782A (zh) | 一种伊维菌素咀嚼片溶出度的测定方法 | |
CN103263411A (zh) | 一种银杏内酯组合物及其应用 | |
CN106168608A (zh) | 一种茶多酚中egcg含量的检测方法 | |
CN104502502A (zh) | 一测多评法测定苦碟子注射液中有机酸含量 | |
CN102841153B (zh) | 一种丹灯通脑药物制剂的质量控制方法 | |
CN104950048A (zh) | 蓝芷安脑胶囊中没食子酸的含量测定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20110907 Assignee: China Medico Corp. Assignor: 302 Military Hospital of China Contract record no.: 2014990000713 Denomination of invention: Biological assay method and device for detecting toxicity potency of aconite traditional Chinese medicines Granted publication date: 20120718 License type: Exclusive License Record date: 20140826 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120718 Termination date: 20220114 |
|
CF01 | Termination of patent right due to non-payment of annual fee |